skip to main content
Idioma:
Refinado por: autor: Fireman, Bruce remover Nome da Publicação: Morbidity And Mortality Weekly Report remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022

Tenforde, Mark W ; Weber, Zachary A ; Natarajan, Karthik ; Klein, Nicola P ; Kharbanda, Anupam B ; Stenehjem, Edward ; Embi, Peter J ; Reese, Sarah E ; Naleway, Allison L ; Grannis, Shaun J ; DeSilva, Malini B ; Ong, Toan C ; Gaglani, Manjusha ; Han, Jungmi ; Dickerson, Monica ; Fireman, Bruce ; Dascomb, Kristin ; Irving, Stephanie A ; Vazquez-Benitez, Gabriela ; Rao, Suchitra ; Konatham, Deepika ; Patel, Palak ; Schrader, Kristin E ; Lewis, Ned ; Grisel, Nancy ; McEvoy, Charlene ; Murthy, Kempapura ; Griggs, Eric P ; Rowley, Elizabeth A K ; Zerbo, Ousseny ; Arndorfer, Julie ; Dunne, Margaret M ; Goddard, Kristin ; Ray, Caitlin ; Zhuang, Yan ; Timbol, Julius ; Najdowski, Morgan ; Yang, Duck-Hye ; Hansen, John ; Ball, Sarah W ; Link-Gelles, Ruth

MMWR. Morbidity and mortality weekly report, 2022-12, Vol.71 (5152), p.1616-1624

United States: U.S. Government Printing Office

Texto completo disponível

Citações Citado por
2
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022

Britton, Amadea ; Embi, Peter J ; Levy, Matthew E ; Gaglani, Manjusha ; DeSilva, Malini B ; Dixon, Brian E ; Dascomb, Kristin ; Patel, Palak ; Schrader, Kristin E ; Klein, Nicola P ; Ong, Toan C ; Natarajan, Karthik ; Hartmann, Emily ; Kharbanda, Anupam B ; Irving, Stephanie A ; Dickerson, Monica ; Dunne, Margaret M ; Raiyani, Chandni ; Grannis, Shaun J ; Stenehjem, Edward ; Zerbo, Ousseny ; Rao, Suchitra ; Han, Jungmi ; Sloan-Aagard, Chantel ; Griggs, Eric P ; Weber, Zachary A ; Murthy, Kempapura ; Fadel, William F ; Grisel, Nancy ; McEvoy, Charlene ; Lewis, Ned ; Barron, Michelle A ; Nanez, Juan ; Reese, Sarah E ; Mamawala, Mufaddal ; Valvi, Nimish R ; Arndorfer, Julie ; Goddard, Kristin ; Yang, Duck-Hye ; Fireman, Bruce ; Ball, Sarah W ; Link-Gelles, Ruth ; Naleway, Allison L ; Tenforde, Mark W

MMWR. Morbidity and mortality weekly report, 2022-10, Vol.71 (42), p.1335-1342

United States: U.S. Government Printing Office

Texto completo disponível

Citações Citado por
3
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022

Natarajan, Karthik ; Prasad, Namrata ; Dascomb, Kristin ; Irving, Stephanie A ; Yang, Duck-Hye ; Gaglani, Manjusha ; Klein, Nicola P ; DeSilva, Malini B ; Ong, Toan C ; Grannis, Shaun J ; Stenehjem, Edward ; Link-Gelles, Ruth ; Rowley, Elizabeth A ; Naleway, Allison L ; Han, Jungmi ; Raiyani, Chandni ; Benitez, Gabriela Vazquez ; Rao, Suchitra ; Lewis, Ned ; Fadel, William F ; Grisel, Nancy ; Griggs, Eric P ; Dunne, Margaret M ; Stockwell, Melissa S ; Mamawala, Mufaddal ; McEvoy, Charlene ; Barron, Michelle A ; Goddard, Kristin ; Valvi, Nimish R ; Arndorfer, Julie ; Patel, Palak ; Mitchell, Patrick K ; Smith, Michael ; Kharbanda, Anupam B ; Fireman, Bruce ; Embi, Peter J ; Dickerson, Monica ; Davis, Jonathan M ; Zerbo, Ousseny ; Dalton, Alexandra F ; Wondimu, Mehiret H ; Azziz-Baumgartner, Eduardo ; Bozio, Catherine H ; Reynolds, Sue ; Ferdinands, Jill ; Williams, Jeremiah ; Schrag, Stephanie J ; Verani, Jennifer R ; Ball, Sarah ; Thompson, Mark G ; Dixon, Brian E

MMWR. Morbidity and mortality weekly report, 2022-04, Vol.71 (13), p.495-502

United States: U.S. Government Printing Office

Texto completo disponível

Citações Citado por
4
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023
Material Type:
Artigo 		Adicionar ao Meu Espaço

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023

Link-Gelles, Ruth ; Weber, Zachary A ; Reese, Sarah E ; Payne, Amanda B ; Gaglani, Manjusha ; Adams, Katherine ; Kharbanda, Anupam B ; Natarajan, Karthik ; DeSilva, Malini B ; Dascomb, Kristin ; Irving, Stephanie A ; Klein, Nicola P ; Grannis, Shaun J ; Ong, Toan C ; Embi, Peter J ; Dunne, Margaret M ; Dickerson, Monica ; McEvoy, Charlene ; Arndorfer, Julie ; Naleway, Allison L ; Goddard, Kristin ; Dixon, Brian E ; Griggs, Eric P ; Hansen, John ; Valvi, Nimish ; Najdowski, Morgan ; Timbol, Julius ; Rogerson, Colin ; Fireman, Bruce ; Fadel, William F ; Patel, Palak ; Ray, Caitlin S ; Wiegand, Ryan ; Ball, Sarah ; Tenforde, Mark W

MMWR. Morbidity and mortality weekly report, 2023-05, Vol.72 (21), p.579-588

United States: U.S. Government Printing Office

Texto completo disponível

Citações Citado por
5
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024
Material Type:
Artigo 		Adicionar ao Meu Espaço

Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024

Link-Gelles, Ruth ; Rowley, Elizabeth A K ; DeSilva, Malini B ; Dascomb, Kristin ; Irving, Stephanie A ; Klein, Nicola P ; Grannis, Shaun J ; Ong, Toan C ; Weber, Zachary A ; Fleming-Dutra, Katherine E ; McEvoy, Charlene E ; Akinsete, Omobosola ; Bride, Daniel ; Sheffield, Tamara ; Naleway, Allison L ; Zerbo, Ousseny ; Fireman, Bruce ; Hansen, John ; Goddard, Kristin ; Dixon, Brian E ; Rogerson, Colin ; Fadel, William F ; Duszynski, Thomas ; Rao, Suchitra ; Barron, Michelle A ; Reese, Sarah E ; Ball, Sarah W ; Dunne, Margaret M ; Natarajan, Karthik ; Okwuazi, Erica ; Shah, Ami B ; Wiegand, Ryan ; Tenforde, Mark W ; Payne, Amanda B

MMWR. Morbidity and mortality weekly report, 2024-03, Vol.73 (12), p.271-276

United States: U.S. Government Printing Office

Texto completo disponível

Citações Citado por
6
COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 15, 2021
COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 15, 2021
Material Type:
Artigo 		Adicionar ao Meu Espaço

COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 15, 2021

Pingali, Cassandra ; Meghani, Mehreen ; Razzaghi, Hilda ; Lamias, Mark J ; Weintraub, Eric ; Kenigsberg, TatYana A ; Klein, Nicola P ; Lewis, Ned ; Fireman, Bruce ; Zerbo, Ousseny ; Bartlett, Joan ; Goddard, Kristin ; Donahue, James ; Hanson, Kayla ; Naleway, Allison ; Kharbanda, Elyse O ; Yih, W.Katherine ; Nelson, Jennifer Clark ; Lewin, Bruno J ; Williams, Joshua T.B ; Glanz, Jason M ; Singleton, James A ; Patel, Suchita A

MMWR. Morbidity and mortality weekly report, 2021-07, Vol.70 (28), p.985-990

Atlanta: U.S. Government Printing Office

Texto completo disponível

Citações Citado por
7
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023

Link-Gelles, Ruth ; Ciesla, Allison Avrich ; Rowley, Elizabeth A.K ; Klein, Nicola P ; Naleway, Allison L ; Payne, Amanda B ; Kharbanda, Anupam ; Natarajan, Karthik ; DeSilva, Malini B ; Dascomb, Kristin ; Irving, Stephanie A ; Zerbo, Ousseny ; Reese, Sarah E ; Wiegand, Ryan E ; Najdowski, Morgan ; Ong, Toan C ; Rao, Suchitra ; Stockwell, Melissa S ; Stephens, Ashley ; Goddard, Kristin ; Martinez, Yessica C ; Weber, Zachary A ; Fireman, Bruce ; Hansen, John ; Timbol, Julius ; Grannis, Shaun J ; Barron, Michelle A ; Embi, Peter J ; Ball, Sarah W ; Gaglani, Manjusha ; Grisel, Nancy ; Arndorfer, Julie ; Tenforde, Mark W ; Fleming-Dutra, Katherine E

MMWR. Morbidity and mortality weekly report, 2023-08, Vol.72 (33), p.886-892

U.S. Government Printing Office

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.